Article Text

Download PDFPDF

IDDF2021-ABS-0056 Liver stiffness plus platelets predicts long-term outcomes in child-pugh a cirrhosis
Free
  1. Tanya Lee1,
  2. Elliot Freeman2,
  3. Daniel Clayton-Chub2,
  4. Stuart Roberts2,
  5. Nik Ding1,
  6. William Kemp2,
  7. Rohit Sawhney2,
  8. John Lubel2,
  9. David Iser1,
  10. Jessica Howell1,
  11. Catherine Croagh1,
  12. Thai Hong1,
  13. Barbara Demediuk1,
  14. Paul Desmond1,
  15. Swee Lin Chen Yi Mei1,
  16. Alexander Thompson1,
  17. Jacinta Holmes1
  1. 1St Vincent’s Hospital, Australia
  2. 2Alfred Health, Australia

Abstract

Background Portal hypertension (PH) remains an important sequela of cirrhosis, contributing to morbidity and mortality. Non-invasive algorithms identifying patients at risk of clinically significant portal hypertension (CSPH) and high-risk gastro-oesophageal varices (varices needing treatment, VNT) are critical. We previously described an algorithm whereby liver stiffness measurement (LSM) ≤25 kPa plus platelets ≥100 excluded VNT in Child-Pugh A cirrhosis. 5 years following the inception of our initial study, this study aimed to assess the prognostic value of LSM ≤25 kPa plus platelets ≥100 in predicting long-term hepatic decompensation and death.

Methods This is a retrospective multicentre study of patients from two tertiary centres. Medical records were reviewed for all subsequent gastroscopies, LSM, six-monthly laboratory tests and abdominal ultrasounds, symptoms/signs consistent with hepatic decompensation (ascites, variceal bleeding, hepatic encephalopathy), and mortality from the initial study date. Patients with an LSM >25 kPa plus platelets <100 were considered high risk for VNT, while patients with LSM ≤25 kPa and/or platelets ≥100 were considered low risk.

Results 180 patients were included. Median age was 55 yrs (IQR 49-63), 70% male, with no significant difference between groups. Median follow-up was 7.7 yrs (4.5-9.0). At study inception, 30/180 (17%) were high risk. The majority (114/180, 63%) had cirrhosis secondary to HCV, similar according to risk group (p=0.752). Decompensation was significantly more common in high-risk patients (11/30 (37%) vs 26/150 (17%) respectively, p=0.016; (IDDF2021-ABS-0056 Figure 1. Decompensation according to high-risk and low-risk category)). 2/150 (1%) low-risk patients were re-classified as high-risk. 19/150 (13%) of low-risk patients had VNT compared to 7/30 (23%) in the high-risk group (p=0.043). There was a trend towards higher mortality in high-risk vs low-risk patients (12/30 (40%) vs 36/150 (24%), respectively, p=0.067; (IDDF2021-ABS-0056 Figure 2. Death according to high-risk and low-risk category)).

Abstract IDDF2021-ABS-0056 Figure 1
Abstract IDDF2021-ABS-0056 Figure 2

Conclusions Our previously defined algorithm of LSM and platelets has prognostic value in predicting for subsequent decompensation and death. LSM+PLT can assist in stratifying future risk of liver-related events in Child-Pugh A cirrhotics.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.